Inpharma Weekly

, Volume 1496, Issue 1, pp 7–7 | Cite as

Galiximab promising for relapsed or refractory follicular lymphoma

Clinical study


Lymphoma Median Time Stable Disease Progressive Disease Clinical Oncology 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2005

Personalised recommendations